Data / Form D filings / Plasmology4, Inc.
Plasmology4, Inc.: Form D filings
Plasmology4, Inc., a biotechnology company in Scottsdale, AZ, filed 14 Form D notices with the SEC between 2010 and 2016. The latest, on December 15, 2016, reports $250,000 sold of a $2 million offering to 1 investor.
Find out what Plasmology4, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8502 East Princess Drive, Suite 210, Scottsdale, AZ, 85255
- Phone
- (480) 342-9840
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1488790
The full lists. Form D filings in Arizona: 953 rows, $47.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 15, 2016 | New notice | $2,000,000 | $250,000 | $1,750,000 | 1 | Dec 13, 2016 | sec.gov |
| Apr 5, 2016 | New notice | $5,000,000 | $125,000 | $4,875,000 | 1 | Mar 28, 2016 | sec.gov |
| Dec 28, 2015 | New notice | $1,000,000 | $1,000,000 | $0 | 1 | Dec 11, 2015 | sec.gov |
| Sep 2, 2015 | New notice | $3,000,000 | $300,000 | $2,700,000 | 1 | Aug 18, 2015 | sec.gov |
| Jul 16, 2014 | New notice | $5,000,000 | $300,000 | $4,700,000 | 2 | Jul 14, 2014 | sec.gov |
| Jun 12, 2014 | New notice | $2,000,000 | $2,000,000 | $0 | 1 | Jun 4, 2014 | sec.gov |
| Feb 11, 2013 | New notice | $10,000,000 | $0 | $10,000,000 | 0 | Yet to occur | sec.gov |
| Dec 19, 2012 | Amendment | $1,800,000 | $905,000 | $895,000 | 18 | Yet to occur | sec.gov |
| Sep 14, 2012 | New notice | $1,500,000 | $0 | $1,500,000 | 0 | Yet to occur | sec.gov |
| Jun 26, 2012 | New notice | $1,000,000 | $1,000,000 | $0 | 1 | Jun 1, 2012 | sec.gov |
| Jan 3, 2012 | New notice | $3,000,000 | $40,000 | $2,960,000 | 1 | Jan 2, 2012 | sec.gov |
| Jul 19, 2011 | New notice | $1,000,000 | $83,663 | $916,337 | 2 | Jun 29, 2011 | sec.gov |
| Jan 31, 2011 | New notice | $525,000 | $362,500 | $162,500 | 5 | Dec 23, 2010 | sec.gov |
| Apr 9, 2010 | New notice | $500,000 | $25,000 | $475,000 | 1 | Mar 24, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert M Hummel | Executive Officer, Director | |
| David J Jacofsky | Executive Officer, Director | |
| Stephen A Brigido | Director | |
| James R Lawson | Director | |
| Andrew W Miller Jr. | Director | |
| Kevin P McDowell | Director | |
| Gregory A Watson | Executive Officer, Director | |
| Ronald D Robinson | Executive Officer, Director | |
| Marc C Jacofsky | Executive Officer |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
Every Form D from the week of Dec 12, 2016 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Plasmology4, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.